All of the ESR1-negative BRCA1 tumours with low expression of NFκB originated from BRCA1 truncating mutations that probably led to a complete absence of the protein through the nonsense-mediated mRNA decay mechanism (NMD) (Supplementary Table S4) (Perrin-Vidoz et al, 2002). The gene discussed is ESR1; the disease is neoplasm.